Sunday, February 10, 2008
I am winding down my clinical practice and will close it as of the end of business June 28, 2018. I am not accepting new patients. Patients who have seen me for treatment in the past seven years are considered to have active charts. To request photocopies, patients with active charts can contact me as they have done in the past. Records for patients who have not seen me clinically in the past seven years are not available. For now, active charts will be kept at 196 Waterman Street, and patients or treating physicians needing access to them or to a summary can contact me as in the past.
Some time ago, I set up this site as an information center and a link to my books. It is not always the most up to date source. Readers are also referred to my publishers [W. W. Norton, Viking, Penguin, Scribner, HarperCollins, and Farrar, Straus and Giroux, among others] and to the information below.
I speak nationally and internationally. For inquiries about speaking engagements and for all literary matters, please contact Andrew Wylie at The Wylie Agency, 250 West 57th Street, Suite 2114, New York, NY 10107, 212-246-0069 or firstname.lastname@example.org.
My most recent book is Ordinarily Well [Farrar, Straus and Giroux, 2016, paperback, 2017].
My most recent book review is Why Are We So Eager to Hear Placebo Speak?"Los Angeles Review of Books, May 3, 2016. Recent essays include: Stumbling Toward Psychiatry, Psychiatric News, January 19, 2018; The FDA Just Approved the First Digital Pill. Here’s How It Could Backfire, Fortune, November 15, 2017; Kramer PD, Satel SL: Who Decides Whether Trump Is Unfit to Govern? New York Times, August 29, 2017; and Kramer PD, Kramer SE: Getting The Shift: Father And Daughter Doctors Debate Intern Workloads, The Forward, March 29, 2017.
Other often-requested pieces include this front-page essay on antidepressants for the New York Times Sunday Review and this review for Slate. Under the "Presentations" heading at this website (above), I've posted the text of a talk, about whether the way we diagnose depression is leading to a "loss of sadness" and another updating my concept "cosmetic psychopharmacology." A debate on the question of antidepressant efficacy in which I participated at Massachusetts General Hospital is posted here.
Regards to all --
Peter D. Kramer
[partly updated April 2018]